| GO ID | GO:0009986 |
| Ontology | CC |
| GO Term | cell surface |
| Definition | The external part of the cell wall and/or plasma membrane. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
TLR4 |
toll-like receptor 4 |
7099 |
O00206 |
chr9: 117,704,332-117,716,871 |
|
ADAM10 |
ADAM metallopeptidase domain 10 |
102 |
O14672 |
chr15: 58,588,807-58,749,978 |
|
NRP1 |
neuropilin 1 |
8829 |
O14786 |
chr10: 33,177,492-33,336,262 |
|
PLXNB2 |
plexin B2 |
23654 |
O15031 |
chr22: 50,274,979-50,307,627 |
|
CAPN5 |
calpain 5 |
726 |
O15484 |
chr11: 77,066,932-77,126,155 |
|
NRDC |
nardilysin convertase |
4898 |
O43847 |
chr1: 51,789,191-51,878,937 |
|
TYROBP |
TYRO protein tyrosine kinase binding protein |
7305 |
O43914 |
chr19: 35,904,401-35,908,295 |
|
FZD6 |
frizzled class receptor 6 |
8323 |
O60353 |
chr8: 103,298,433-103,332,866 |
|
GREM1 |
gremlin 1, DAN family BMP antagonist |
26585 |
O60565 |
chr15: 32,717,974-32,745,107 |
|
TLR2 |
toll-like receptor 2 |
7097 |
O60603 |
chr4: 153,701,500-153,705,699 |
|
SRPX2 |
sushi-repeat containing protein, X-linked 2 |
27286 |
O60687 |
chrX: 100,644,166-100,675,788 |
|
RAMP1 |
receptor (G protein-coupled) activity modifying protein 1 |
10267 |
O60894 |
chr2: 237,858,893-237,912,114 |
|
RAMP3 |
receptor (G protein-coupled) activity modifying protein 3 |
10268 |
O60896 |
chr7: 45,157,791-45,186,302 |
|
SDC3 |
syndecan 3 |
9672 |
O75056 |
chr1: 30,869,467-30,908,761 |
|
HMMR |
hyaluronan-mediated motility receptor (RHAMM) |
3161 |
O75330 |
chr5: 163,460,203-163,491,945 |
|
ENTPD6 |
ectonucleoside triphosphate diphosphohydrolase 6 (putative) |
955 |
O75354 |
chr20: 25,195,693-25,226,729 |
|
VAMP4 |
vesicle associated membrane protein 4 |
8674 |
O75379 |
chr1: 171,700,160-171,742,247 |
|
LRP6 |
LDL receptor related protein 6 |
4040 |
O75581 |
chr12: 12,116,025-12,267,012 |
|
CLSTN1 |
calsyntenin 1 |
22883 |
O94985 |
chr1: 9,729,026-9,824,526 |
|
CSPG5 |
chondroitin sulfate proteoglycan 5 |
10675 |
O95196 |
chr3: 47,562,239-47,580,792 |
|
MPZL1 |
myelin protein zero-like 1 |
9019 |
O95297 |
chr1: 167,721,192-167,791,919 |
|
BMP10 |
bone morphogenetic protein 10 |
27302 |
O95393 |
chr2: 68,865,481-68,871,517 |
|
GOT2 |
glutamic-oxaloacetic transaminase 2 |
2806 |
P00505 |
chr16: 58,707,131-58,734,357 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
PLG |
plasminogen |
5340 |
P00747 |
chr6: 160,702,238-160,753,315 |
|
PLAU |
plasminogen activator, urokinase |
5328 |
P00749 |
chr10: 73,909,177-73,917,497 |
|
PLAT |
plasminogen activator, tissue |
5327 |
P00750 |
chr8: 42,175,233-42,207,724 |
|
ADA |
adenosine deaminase |
100 |
P00813 |
chr20: 44,619,522-44,652,233 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
LDLR |
low density lipoprotein receptor |
3949 |
P01130 |
chr19: 11,089,362-11,133,816 |
|
TGFA |
transforming growth factor alpha |
7039 |
P01135 |
chr2: 70,447,280-70,554,193 |
|
TGFB1 |
transforming growth factor beta 1 |
7040 |
P01137 |
chr19: 41,301,587-41,353,911 |
|
TNF |
tumor necrosis factor |
7124 |
P01375 |
chr6: 31,575,567-31,578,336 |
|
HLA-B |
major histocompatibility complex, class I, B |
3106 |
P01889 |
chr6: 31,269,491-31,357,188 |
|
HLA-DRA |
major histocompatibility complex, class II, DR alpha |
3122 |
P01903 |
chr6: 32,439,842-32,445,046 |
|
CRYAB |
crystallin alpha B |
1410 |
P02511 |
chr11: 111,908,565-111,923,722 |
|
APOA1 |
apolipoprotein A-I |
335 |
P02647 |
chr11: 116,835,751-116,837,950 |
|
FGA |
fibrinogen alpha chain |
2243 |
P02671 |
chr4: 154,583,126-154,590,766 |
|
FGB |
fibrinogen beta chain |
2244 |
P02675 |
chr4: 154,562,956-154,571,086 |
|
FGG |
fibrinogen gamma chain |
2266 |
P02679 |
chr4: 154,604,134-154,612,967 |
|
APOH |
apolipoprotein H |
350 |
P02749 |
chr17: 66,212,033-66,256,525 |
|
AMBP |
alpha-1-microglobulin/bikunin precursor |
259 |
P02760 |
chr9: 114,060,127-114,078,472 |
|
TFRC |
transferrin receptor |
7037 |
P02786 |
chr3: 196,027,183-196,082,189 |
|
TF |
transferrin |
7018 |
P02787 |
chr3: 133,745,956-133,779,006 |
|
ANXA1 |
annexin A1 |
301 |
P04083 |
chr9: 73,151,757-73,170,393 |
|
PDGFA |
platelet-derived growth factor alpha polypeptide |
5154 |
P04085 |
chr7: 497,258-520,296 |
|
PRNP |
prion protein |
5621 |
P04156 |
chr20: 4,686,236-4,701,590 |
|
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
972 |
P04233 |
chr5: 150,401,637-150,412,929 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
APP |
amyloid beta (A4) precursor protein |
351 |
P05067 |
chr21: 25,880,550-26,171,128 |
|
ITGB3 |
integrin subunit beta 3 |
3690 |
P05106 |
chr17: 47,253,846-47,311,816 |
|
ITGB2 |
integrin subunit beta 2 |
3689 |
P05107 |
chr21: 44,885,953-44,931,989 |
|
ICAM1 |
intercellular adhesion molecule 1 |
3383 |
P05362 |
chr19: 10,270,835-10,286,615 |
|
ITGB1 |
integrin subunit beta 1 |
3688 |
P05556 |
chr10: 32,900,319-33,005,792 |
|
ITGAV |
integrin subunit alpha V |
3685 |
P06756 |
chr2: 186,590,065-186,680,901 |
|
LPL |
lipoprotein lipase |
4023 |
P06858 |
chr8: 19,901,717-19,967,258 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
ANXA2 |
annexin A2 |
302 |
P07355 |
chr15: 60,347,134-60,402,883 |
|
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
|
THBS1 |
thrombospondin 1 |
7057 |
P07996 |
chr15: 39,581,079-39,599,466 |
|
NGFR |
nerve growth factor receptor |
4804 |
P08138 |
chr17: 49,495,293-49,515,017 |
|
CD55 |
CD55 molecule, decay accelerating factor for complement (Cromer blood group) |
1604 |
P08174 |
chr1: 207,321,508-207,386,804 |
|
SLC3A2 |
solute carrier family 3 (amino acid transporter heavy chain), member 2 |
6520 |
P08195 |
chr11: 62,856,102-62,888,875 |
|
HSP90AB1 |
heat shock protein 90kDa alpha family class B member 1 |
3326 |
P08238 |
chr6: 44,246,166-44,253,888 |
|
PTPRC |
protein tyrosine phosphatase, receptor type, C |
5788 |
P08575 |
chr1: 198,638,671-198,757,283 |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
|
MFI2 |
antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5 |
4241 |
P08582 |
chr3: 196,988,621-197,029,816 |
|
ITGA5 |
integrin subunit alpha 5 |
3678 |
P08648 |
chr12: 54,395,261-54,419,460 |
|
IL6R |
interleukin 6 receptor |
3570 |
P08887 |
chr1: 154,405,193-154,469,450 |
|
LGALS1 |
lectin, galactoside-binding, soluble, 1 |
3956 |
P09382 |
chr22: 37,675,608-37,679,806 |
|
HMGB1 |
high mobility group box 1 |
3146 |
P09429 |
chr13: 30,456,704-30,617,597 |
|
SPARC |
secreted protein, acidic, cysteine-rich (osteonectin) |
6678 |
P09486 |
chr5: 151,661,096-151,687,165 |
|
ANXA4 |
annexin A4 |
307 |
P09525 |
chr2: 69,644,425-69,827,100 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
FURIN |
furin (paired basic amino acid cleaving enzyme) |
5045 |
P09958 |
chr15: 90,868,592-90,883,458 |
|
TFPI |
tissue factor pathway inhibitor |
7035 |
P10646 |
chr2: 187,464,230-187,565,760 |
|
CD28 |
CD28 molecule |
940 |
P10747 |
chr2: 203,706,475-203,738,912 |
|
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
3329 |
P10809 |
chr2: 197,486,581-197,516,737 |
|
CLU |
clusterin |
1191 |
P10909 |
chr8: 27,596,917-27,615,031 |
|
GHR |
growth hormone receptor |
2690 |
P10912 |
chr5: 42,423,777-42,721,878 |
|
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
3309 |
P11021 |
chr9: 125,234,853-125,241,330 |
|
ITGAM |
integrin subunit alpha M |
3684 |
P11215 |
chr16: 31,259,990-31,332,892 |
|
MBL2 |
mannose-binding lectin (protein C) 2, soluble |
4153 |
P11226 |
chr10: 52,765,380-52,771,700 |
|
RALA |
v-ral simian leukemia viral oncogene homolog A (ras related) |
5898 |
P11233 |
chr7: 39,623,483-39,708,124 |
|
DMD |
dystrophin |
1756 |
P11532 |
chrX: 31,097,677-33,339,441 |
|
IGF2R |
insulin like growth factor 2 receptor |
3482 |
P11717 |
chr6: 159,969,099-160,113,507 |
|
BMP2 |
bone morphogenetic protein 2 |
650 |
P12643 |
chr20: 6,767,664-6,780,280 |
|
TDGF1 |
teratocarcinoma-derived growth factor 1 |
6997 |
P13385 |
chr3: 46,574,534-46,582,463 |
|
CFTR |
cystic fibrosis transmembrane conductance regulator |
1080 |
P13569 |
chr7: 117,465,784-117,715,971 |
|
NCAM1 |
neural cell adhesion molecule 1 |
4684 |
P13591 |
chr11: 112,961,247-113,278,436 |
|
PDIA4 |
protein disulfide isomerase family A member 4 |
9601 |
P13667 |
chr7: 149,003,062-149,028,641 |
|
HLA-E |
major histocompatibility complex, class I, E |
3133 |
P13747 |
chr6: 30,489,467-30,494,205 |
|
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
4282 |
P14174 |
chr22: 23,894,004-23,895,227 |
|
CPM |
carboxypeptidase M |
1368 |
P14384 |
chr12: 68,842,197-68,971,570 |
|
IDE |
insulin-degrading enzyme |
3416 |
P14735 |
chr10: 92,451,684-92,574,076 |
|
IL1R1 |
interleukin 1 receptor, type I |
3554 |
P14778 |
chr2: 102,064,544-102,179,874 |
|
PVR |
poliovirus receptor |
5817 |
P15151 |
chr19: 44,643,798-44,663,583 |
|
FOLR1 |
folate receptor 1 (adult) |
2348 |
P15328 |
chr11: 72,189,558-72,196,323 |
|
AREG |
amphiregulin |
374 |
P15514 |
chr4: 74,445,134-74,455,009 |
|
CD46 |
CD46 molecule, complement regulatory protein |
4179 |
P15529 |
chr1: 207,752,057-207,795,513 |
|
VEGFA |
vascular endothelial growth factor A |
7422 |
P15692 |
chr6: 43,770,184-43,786,487 |
|
CD1D |
CD1d molecule |
912 |
P15813 |
chr1: 158,179,947-158,184,896 |
|
ARSB |
arylsulfatase B |
411 |
P15848 |
chr5: 78,777,209-78,986,087 |
|
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
7077 |
P16035 |
chr17: 78,852,977-78,925,387 |
|
CD44 |
CD44 molecule (Indian blood group) |
960 |
P16070 |
chr11: 35,138,870-35,232,402 |
|
ITGB4 |
integrin subunit beta 4 |
3691 |
P16144 |
chr17: 75,721,328-75,757,818 |
|
EPCAM |
epithelial cell adhesion molecule |
4072 |
P16422 |
chr2: 47,345,158-47,387,601 |
|
PRLR |
prolactin receptor |
5618 |
P16471 |
chr5: 35,048,756-35,230,589 |
|
CD36 |
CD36 molecule (thrombospondin receptor) |
948 |
P16671 |
chr7: 80,369,575-80,679,277 |
|
ITGA2 |
integrin subunit alpha 2 |
3673 |
P17301 |
chr5: 52,989,326-53,094,779 |
|
CR1 |
complement component (3b/4b) receptor 1 (Knops blood group) |
1378 |
P17927 |
chr1: 207,496,147-207,640,647 |
|
ITGB5 |
integrin subunit beta 5 |
3693 |
P18084 |
chr3: 124,761,948-124,901,418 |
|
SDC1 |
syndecan 1 |
6382 |
P18827 |
chr2: 20,200,797-20,225,433 |
|
PAM |
peptidylglycine alpha-amidating monooxygenase |
5066 |
P19021 |
chr5: 102,753,981-103,031,105 |
|
CD58 |
CD58 molecule |
965 |
P19256 |
chr1: 116,514,535-116,571,039 |
|
VCAM1 |
vascular cell adhesion molecule 1 |
7412 |
P19320 |
chr1: 100,719,742-100,739,045 |
|
CD53 |
CD53 molecule |
963 |
P19397 |
chr1: 110,873,154-110,899,928 |
|
HLA-DPA1 |
major histocompatibility complex, class II, DP alpha 1 |
3113 |
P20036 |
chr6: 33,064,569-33,080,775 |
|
ITGAX |
integrin subunit alpha X |
3687 |
P20702 |
chr16: 31,355,134-31,382,997 |
|
NT5E |
5'-nucleotidase, ecto (CD73) |
4907 |
P21589 |
chr6: 85,449,584-85,495,791 |
|
C5AR1 |
complement component 5a receptor 1 |
728 |
P21730 |
chr19: 47,290,023-47,322,066 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
BGN |
biglycan |
633 |
P21810 |
chrX: 153,494,939-153,509,554 |
|
FUT4 |
fucosyltransferase 4 |
2526 |
P22083 |
chr11: 94,543,840-94,549,898 |
|
ENPP1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
5167 |
P22413 |
chr6: 131,808,016-131,895,155 |
|
CA4 |
carbonic anhydrase IV |
762 |
P22748 |
chr17: 60,149,936-60,170,899 |
|
MRC1 |
mannose receptor, C type 1 |
4360 |
P22897 |
chr10: 17,809,344-17,911,170 |
|
ITGA6 |
integrin subunit alpha 6 |
3655 |
P23229 |
chr2: 172,427,354-172,506,282 |
|
TNFSF4 |
tumor necrosis factor superfamily member 4 |
7292 |
P23510 |
chr1: 173,183,734-173,207,313 |
|
CXCR2 |
chemokine (C-X-C motif) receptor 2 |
3579 |
P25025 |
chr2: 218,125,289-218,137,253 |
|
CD24 |
CD24 molecule |
100133941 |
P25063 |
chr6: 106,969,831-106,975,627 |
|
F2R |
coagulation factor II (thrombin) receptor |
2149 |
P25116 |
chr5: 76,716,043-76,735,781 |
|
FAS |
Fas cell surface death receptor |
355 |
P25445 |
chr10: 88,990,582-89,015,785 |
|
ITGA3 |
integrin subunit alpha 3 |
3675 |
P26006 |
chr17: 50,055,968-50,090,481 |
|
ITGB8 |
integrin subunit beta 8 |
3696 |
P26012 |
chr7: 20,330,702-20,415,754 |
|
ACVR2A |
activin A receptor type IIA |
92 |
P27037 |
chr2: 147,844,517-147,930,826 |
|
DPP4 |
dipeptidyl-peptidase 4 |
1803 |
P27487 |
chr2: 161,992,241-162,074,542 |
|
CALR |
calreticulin |
811 |
P27797 |
chr19: 12,938,578-12,944,489 |
|
PCSK6 |
proprotein convertase subtilisin/kexin type 6 |
5046 |
P29122 |
chr15: 101,297,142-101,525,202 |
|
CD40LG |
CD40 ligand |
959 |
P29965 |
chrX: 136,648,193-136,660,390 |
|
ERP29 |
endoplasmic reticulum protein 29 |
10961 |
P30040 |
chr12: 112,013,316-112,023,451 |
|
PDIA3 |
protein disulfide isomerase family A member 3 |
2923 |
P30101 |
chr15: 43,746,392-43,773,279 |
|
HLA-A |
major histocompatibility complex, class I, A |
3105 |
P30443 |
chr6: 29,941,260-29,945,884 |
|
HLA-F |
major histocompatibility complex, class I, F |
3134 |
P30511 |
chr6: 29,722,775-29,738,528 |
|
SLC6A1 |
solute carrier family 6 (neurotransmitter transporter), member 1 |
6529 |
P30531 |
chr3: 10,992,724-11,039,247 |
|
LRPAP1 |
LDL receptor related protein associated protein 1 |
4043 |
P30533 |
chr4: 3,506,376-3,532,559 |
|
SDC4 |
syndecan 4 |
6385 |
P31431 |
chr20: 45,325,288-45,348,424 |
|
CDH5 |
cadherin 5, type 2 (vascular endothelium) |
1003 |
P33151 |
chr16: 66,366,622-66,404,786 |
|
SDC2 |
syndecan 2 |
6383 |
P34741 |
chr8: 96,493,351-96,611,780 |
|
PHB |
prohibitin |
5245 |
P35232 |
chr17: 49,404,049-49,414,905 |
|
ACVR1B |
activin A receptor type IB |
91 |
P36896 |
chr12: 51,951,667-51,997,078 |
|
TGFBR1 |
transforming growth factor beta receptor I |
7046 |
P36897 |
chr9: 99,104,038-99,154,192 |
|
WNT5A |
wingless-type MMTV integration site family member 5A |
7474 |
P41221 |
chr3: 55,465,715-55,490,539 |
|
ADCYAP1R1 |
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I |
117 |
P41586 |
chr7: 31,052,461-31,111,479 |
|
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
6507 |
P43003 |
chr5: 36,606,355-36,688,334 |
|
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
6506 |
P43004 |
chr11: 35,251,206-35,420,063 |
|
SLC1A4 |
solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 |
6509 |
P43007 |
chr2: 64,988,477-65,023,865 |
|
NOTCH1 |
notch 1 |
4851 |
P46531 |
chr9: 136,494,444-136,545,862 |
|
SLC11A2 |
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2 |
4891 |
P49281 |
chr12: 50,979,401-51,028,566 |
|
PSEN1 |
presenilin 1 |
5663 |
P49768 |
chr14: 73,136,418-73,223,691 |
|
MMP16 |
matrix metallopeptidase 16 |
4325 |
P51512 |
chr8: 88,032,009-88,328,025 |
|
CLCN3 |
chloride channel, voltage-sensitive 3 |
1182 |
P51790 |
chr4: 169,612,633-169,723,673 |
|
VAMP7 |
vesicle associated membrane protein 7 |
6845 |
P51809 |
chrX: 155,881,293-155,943,769 |
|
EPHA4 |
EPH receptor A4 |
2043 |
P54764 |
chr2: 221,418,027-221,574,202 |
|
EMP2 |
epithelial membrane protein 2 |
2013 |
P54851 |
chr16: 10,528,422-10,580,698 |
|
SYNJ2BP |
synaptojanin 2 binding protein |
55333 |
P57105 |
chr14: 70,366,496-70,417,061 |
|
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
7852 |
P61073 |
chr2: 136,114,349-136,118,165 |
|
CXADR |
coxsackie virus and adenovirus receptor |
1525 |
P78310 |
chr21: 17,512,382-17,593,579 |
|
ADAM8 |
ADAM metallopeptidase domain 8 |
101 |
P78325 |
chr10: 133,262,403-133,276,868 |
|
ADAM17 |
ADAM metallopeptidase domain 17 |
6868 |
P78536 |
chr2: 9,488,486-9,555,792 |
|
PKD1 |
polycystic kidney disease 1 (autosomal dominant) |
5310 |
P98161 |
chr16: 2,088,710-2,135,898 |
|
NDP |
Norrie disease (pseudoglioma) |
4693 |
Q00604 |
chrX: 43,948,776-43,973,504 |
|
HNRNPU |
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) |
3192 |
Q00839 |
chr1: 244,840,638-244,864,560 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
TGFBR3 |
transforming growth factor beta receptor III |
7049 |
Q03167 |
chr1: 91,680,343-91,906,335 |
|
NOTCH2 |
notch 2 |
4853 |
Q04721 |
chr1: 119,911,553-120,069,626 |
|
C1QBP |
complement component 1, q subcomponent binding protein |
708 |
Q07021 |
chr17: 5,432,777-5,448,830 |
|
KCNA1 |
potassium channel, voltage gated shaker related subfamily A, member 1 |
3736 |
Q09470 |
chr12: 4,909,893-4,918,256 |
|
BST2 |
bone marrow stromal cell antigen 2 |
684 |
Q10589 |
chr19: 17,402,939-17,405,648 |
|
KCNH2 |
potassium channel, voltage gated eag related subfamily H, member 2 |
3757 |
Q12809 |
chr7: 150,944,961-150,978,315 |
|
STX4 |
syntaxin 4 |
6810 |
Q12846 |
chr16: 31,032,889-31,042,975 |
|
CDH17 |
cadherin 17, LI cadherin (liver-intestine) |
1015 |
Q12864 |
chr8: 94,127,171-94,217,303 |
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
2903 |
Q12879 |
chr16: 9,753,404-10,182,754 |
|
HYAL2 |
hyaluronoglucosaminidase 2 |
8692 |
Q12891 |
chr3: 50,317,790-50,322,906 |
|
PTPRJ |
protein tyrosine phosphatase, receptor type, J |
5795 |
Q12913 |
chr11: 47,980,558-48,170,841 |
|
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
288 |
Q12955 |
chr10: 60,026,298-60,733,490 |
|
SLC39A6 |
solute carrier family 39 (zinc transporter), member 6 |
25800 |
Q13433 |
chr18: 36,108,532-36,129,385 |
|
ADAM9 |
ADAM metallopeptidase domain 9 |
8754 |
Q13443 |
chr8: 38,996,869-39,105,144 |
|
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
10788 |
Q13576 |
chr5: 76,403,249-76,708,132 |
|
BMPR2 |
bone morphogenetic protein receptor type II |
659 |
Q13873 |
chr2: 202,376,936-202,567,751 |
|
DSG2 |
desmoglein 2 |
1829 |
Q14126 |
chr18: 31,498,043-31,549,008 |
|
DIP2A |
disco interacting protein 2 homolog A |
23181 |
Q14689 |
chr21: 46,458,899-46,569,852 |
|
PTPRK |
protein tyrosine phosphatase, receptor type, K |
5796 |
Q15262 |
chr6: 127,968,779-128,520,674 |
|
VAMP3 |
vesicle associated membrane protein 3 |
9341 |
Q15836 |
chr1: 7,771,269-7,781,432 |
|
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
9370 |
Q15848 |
chr3: 186,842,690-186,858,463 |
|
AOC3 |
amine oxidase, copper containing 3 |
8639 |
Q16853 |
chr17: 42,851,184-42,858,130 |
|
MICB |
MHC class I polypeptide-related sequence B |
4277 |
Q29980 |
chr6: 31,494,881-31,511,124 |
|
MICA |
MHC class I polypeptide-related sequence A |
100507436 |
Q29983 |
chr6: 31,399,784-31,415,315 |
|
ANO6 |
anoctamin 6 |
196527 |
Q4KMQ2 |
chr12: 45,215,987-45,440,404 |
|
SFRP4 |
secreted frizzled-related protein 4 |
6424 |
Q6FHJ7 |
chr7: 37,905,932-38,025,695 |
|
CSPG4 |
chondroitin sulfate proteoglycan 4 |
1464 |
Q6UVK1 |
chr15: 75,674,322-75,712,848 |
|
RTN4RL1 |
reticulon 4 receptor-like 1 |
146760 |
Q86UN2 |
chr17: 1,934,677-2,025,345 |
|
LRRC8A |
leucine-rich repeat containing 8 family member A |
56262 |
Q8IWT6 |
chr9: 128,882,112-128,918,039 |
|
SULF2 |
sulfatase 2 |
55959 |
Q8IWU5 |
chr20: 47,656,348-47,786,616 |
|
SULF1 |
sulfatase 1 |
23213 |
Q8IWU6 |
chr8: 69,466,624-69,660,915 |
|
SCUBE1 |
signal peptide, CUB domain, EGF-like 1 |
80274 |
Q8IWY4 |
chr22: 43,197,283-43,343,388 |
|
SCUBE3 |
signal peptide, CUB domain, EGF-like 3 |
222663 |
Q8IX30 |
chr6: 35,214,419-35,253,079 |
|
NLGN4X |
neuroligin 4, X-linked |
57502 |
Q8N0W4 |
chrX: 5,840,637-6,228,863 |
|
NLGN1 |
neuroligin 1 |
22871 |
Q8N2Q7 |
chr3: 173,396,284-174,286,644 |
|
SFRP1 |
secreted frizzled-related protein 1 |
6422 |
Q8N474 |
chr8: 41,261,958-41,309,497 |
|
PCSK9 |
proprotein convertase subtilisin/kexin type 9 |
255738 |
Q8NBP7 |
chr1: 55,039,548-55,064,852 |
|
TSPAN14 |
tetraspanin 14 |
81619 |
Q8NG11 |
chr10: 80,454,166-80,533,123 |
|
CYP2W1 |
cytochrome P450 family 2 subfamily W member 1 |
54905 |
Q8TAV3 |
chr7: 983,199-989,640 |
|
HM13 |
histocompatibility (minor) 13 |
81502 |
Q8TCT9 |
chr20: 31,514,428-31,577,923 |
|
ADAMTS15 |
ADAM metallopeptidase with thrombospondin type 1 motif 15 |
170689 |
Q8TE58 |
chr11: 130,448,974-130,476,641 |
|
DEFB104A |
defensin beta 104B |
503618 |
Q8WTQ1 |
chr8: 7,470,308-7,475,082 |
|
SCARB1 |
scavenger receptor class B member 1 |
949 |
Q8WTV0 |
chr12: 124,776,856-124,882,668 |
|
GPR98 |
adhesion G protein-coupled receptor V1 |
84059 |
Q8WXG9 |
chr5: 90,529,344-91,164,437 |
|
TNR |
tenascin R |
7143 |
Q92752 |
chr1: 175,315,194-175,743,770 |
|
GHSR |
growth hormone secretagogue receptor |
2693 |
Q92847 |
chr3: 172,445,133-172,448,456 |
|
KISS1R |
KISS1 receptor |
84634 |
Q969F8 |
chr19: 917,287-921,015 |
|
SLC46A1 |
solute carrier family 46 (folate transporter), member 1 |
113235 |
Q96NT5 |
chr17: 28,394,756-28,407,197 |
|
DCBLD2 |
discoidin, CUB and LCCL domain containing 2 |
131566 |
Q96PD2 |
chr3: 98,795,941-98,901,689 |
|
HHIP |
hedgehog interacting protein |
64399 |
Q96QV1 |
chr4: 144,646,021-144,745,271 |
|
HBEGF |
heparin-binding EGF-like growth factor |
1839 |
Q99075 |
chr5: 140,332,843-140,346,631 |
|
PHB2 |
prohibitin 2 |
11331 |
Q99623 |
chr12: 6,965,327-6,970,825 |
|
ERP44 |
endoplasmic reticulum protein 44 |
23071 |
Q9BS26 |
chr9: 99,979,179-100,099,040 |
|
SLC46A2 |
solute carrier family 46 member 2 |
57864 |
Q9BY10 |
chr9: 112,878,920-112,890,913 |
|
ULBP2 |
UL16 binding protein 2 |
80328 |
Q9BZM5 |
chr6: 149,942,000-149,949,235 |
|
WNT5B |
wingless-type MMTV integration site family member 5B |
81029 |
Q9H1J7 |
chr12: 1,529,891-1,647,243 |
|
CLSTN2 |
calsyntenin 2 |
64084 |
Q9H4D0 |
chr3: 139,935,185-140,577,397 |
|
C10orf54 |
chromosome 10 open reading frame 54 |
64115 |
Q9H7M9 |
chr10: 71,747,559-71,773,498 |
|
TMEM206 |
transmembrane protein 206 |
55248 |
Q9H813 |
chr1: 212,363,931-212,414,901 |
|
TRPV4 |
transient receptor potential cation channel, subfamily V, member 4 |
59341 |
Q9HBA0 |
chr12: 109,783,085-109,833,401 |
|
RC3H2 |
ring finger and CCCH-type domains 2 |
54542 |
Q9HBD1 |
chr9: 122,844,556-122,905,341 |
|
TNS1 |
tensin 1 |
7145 |
Q9HBL0 |
chr2: 217,799,789-218,002,995 |
|
ROBO2 |
roundabout guidance receptor 2 |
6092 |
Q9HCK4 |
chr3: 75,906,695-77,649,964 |
|
APMAP |
adipocyte plasma membrane associated protein |
57136 |
Q9HDC9 |
chr20: 24,962,925-24,992,979 |
|
CD209 |
CD209 molecule |
30835 |
Q9NNX6 |
chr19: 7,739,994-7,747,564 |
|
TNFRSF12A |
tumor necrosis factor receptor superfamily member 12A |
51330 |
Q9NP84 |
chr16: 3,018,445-3,022,383 |
|
CD93 |
CD93 molecule |
22918 |
Q9NPY3 |
chr20: 23,079,349-23,086,340 |
|
PDGFC |
platelet derived growth factor C |
56034 |
Q9NRA1 |
chr4: 156,760,454-156,971,394 |
|
IL17RB |
interleukin 17 receptor B |
55540 |
Q9NRM6 |
chr3: 53,846,580-53,865,800 |
|
CLDND1 |
claudin domain containing 1 |
56650 |
Q9NY35 |
chr3: 98,497,912-98,523,066 |
|
GPRC5B |
G protein-coupled receptor, class C, group 5, member B |
51704 |
Q9NZH0 |
chr16: 19,856,691-19,886,167 |
|
ADAMTS9 |
ADAM metallopeptidase with thrombospondin type 1 motif 9 |
56999 |
Q9P2N4 |
chr3: 64,515,654-64,688,000 |
|
ADAMTS7 |
ADAM metallopeptidase with thrombospondin type 1 motif 7 |
11173 |
Q9UKP4 |
chr15: 78,759,203-78,811,431 |
|
NRXN1 |
neurexin 1 |
9378 |
Q9ULB1 |
chr2: 49,918,505-51,225,575 |
|
INTU |
inturned planar cell polarity protein |
27152 |
Q9ULD6 |
chr4: 127,623,271-127,726,737 |
|
FZD4 |
frizzled class receptor 4 |
8322 |
Q9ULV1 |
chr11: 86,945,679-86,955,391 |
|
PROCR |
protein C receptor |
10544 |
Q9UNN8 |
chr20: 35,172,073-35,216,240 |
|
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
23657 |
Q9UPY5 |
chr4: 138,164,097-138,242,349 |
|
TLN1 |
talin 1 |
7094 |
Q9Y490 |
chr9: 35,696,948-35,732,395 |
|
HILPDA |
hypoxia inducible lipid droplet-associated |
29923 |
Q9Y5L2 |
chr7: 128,455,849-128,458,418 |
|
TRPV2 |
transient receptor potential cation channel, subfamily V, member 2 |
51393 |
Q9Y5S1 |
chr17: 16,415,542-16,437,003 |
|
LIPG |
lipase, endothelial |
9388 |
Q9Y5X9 |
chr18: 49,560,699-49,599,182 |
|
WNT6 |
wingless-type MMTV integration site family member 6 |
7475 |
Q9Y6F9 |
chr2: 218,859,821-218,874,233 |